Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income Tax (Details) - Schedule of deferred income taxes

v3.22.1
Income Tax (Details) - Schedule of deferred income taxes - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Schedule of deferred income taxes [Abstract]    
Net operating loss carry forward $ 14,391 $ 14,693
Research and development expenses 1,280 823
Valuation of financial instruments (6) (10)
Less – valuation allowance (15,665) (15,506)
Net deferred tax assets